ProCE Banner Activity

Understanding BCL-2 Inhibitor Treatment and Management of Potential Side Effects

PDF

Downloadable patient resource for healthcare professionals to use when discussing venetoclax therapy for acute myeloid leukemia or chronic lymphocytic leukemia/small lymphocytic lymphoma, including side effect management.

Released: May 20, 2024

Expiration: May 19, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from AbbVie Inc.

AbbVie Inc.